3D printing is used across nearly every branch of medicine, from printing titanium hip implants and surgical planning models to fabricating dental crowns, prosthetic limbs, and even living tissue. The technology has moved well beyond novelty status: the FDA now regulates 3D-printed medical devices, biologics, and drugs, and hospitals increasingly operate their own in-house printing labs. Here’s how it works in practice.
Custom Implants and Orthopedic Hardware
One of the most established medical uses of 3D printing is manufacturing implants tailored to a single patient’s anatomy. Orthopedic and cranial implants, in particular, benefit from this approach. Traditional implants come in standard sizes, which means surgeons sometimes have to compromise on fit. A 3D-printed implant is designed from the patient’s own CT or MRI scan, matching the exact contours of the bone it will replace or reinforce.
Most orthopedic implants are printed in titanium, and the printing process offers a specific biological advantage: the surface can be made porous on purpose. Bone cells grow into those tiny pores and lock the implant in place over time, a process called osseointegration. Patient-specific implants also reduce a problem known as stress shielding, where a too-stiff implant absorbs forces that the surrounding bone needs in order to stay healthy. By controlling the internal structure of the printed metal, engineers can dial in stiffness that more closely matches natural bone, allowing better nutrient flow and blood vessel formation around the implant.
A high-performance plastic called PEEK is also gaining traction for implants. It’s chemically resistant, doesn’t interfere with imaging scans the way metal can, and its stiffness is closer to bone than titanium is. PEEK implants are already used in spinal surgery and as dental prosthetics.
Surgical Planning and Guides
Before a complex operation, surgeons can now hold a physical replica of the anatomy they’re about to operate on. These patient-specific models, printed from imaging data, let the surgical team rehearse the procedure, identify tricky anatomy, and plan their approach in three dimensions rather than on a flat screen.
The clinical results are striking. In one set of thoracic surgeries, the team that used 3D-printed models identified vascular variations before making an incision and had zero unplanned conversions to open surgery. The control group, working without models, had four emergency conversions due to unexpected blood vessel anatomy. Studies in liver surgery, kidney transplants in children, and living-donor liver transplants have all shown fewer complications and shorter anesthesia times when 3D models were part of the planning process.
3D-printed surgical guides, which clip onto bone or tissue to direct a saw or drill along a pre-planned path, save an average of 23 minutes of operating room time per case. That translates to roughly $1,488 in cost savings per procedure just from reduced OR time, not counting the potential reduction in complications. Printed puncture guides improve the accuracy of needle or channel placement while reducing blood loss. In cancer surgery, patient-specific cutting guides have been linked to lower local recurrence rates because the resection margins are more precise.
Training the Next Generation of Surgeons
3D-printed anatomical models are filling a critical gap in surgical education. Trainees can practice procedures like ear tube placement, sinus surgery, skull base surgery, and airway management on realistic physical models before ever touching a patient. The tactile feedback is particularly valuable for understanding how blood vessels and nerves relate to each other in three-dimensional space, something a textbook or even a video can’t fully convey.
Otolaryngology fellows who trained on 3D-printed models reported statistically significant increases in self-reported confidence and perceived expertise. For junior surgeons across specialties, these models compress the learning curve and reduce the risks that come with gaining experience exclusively in the operating room.
Prosthetic Limbs
Conventional prosthetic limbs can cost tens of thousands of dollars, require multiple fitting appointments, and take weeks to fabricate. 3D printing has opened up a much wider cost spectrum. At the low end, the nonprofit e-NABLE has facilitated basic 3D-printed prosthetic hands for children at a material cost of $15 to $20. These are simple, mechanically operated devices, but for a growing child who will outgrow a prosthesis in months, they offer function without a massive financial commitment.
More advanced options exist too. One company developed a multi-articulating myoelectric hand (a prosthesis controlled by muscle signals) priced at around $7,000, roughly one-tenth the cost of comparable German-made devices that bill insurance for tens of thousands of dollars. The challenge has been navigating the insurance and clinical infrastructure: prosthetists must decide whether to bill for the cheaper printed option or the traditional device, and even $7,000 out of pocket remains prohibitive for many patients. The technology is promising, but cost alone hasn’t yet solved the access problem.
Dental Applications
Dentistry has adopted 3D printing faster than almost any other medical specialty. Crowns, bridges, surgical guides for implant placement, and orthodontic aligners are all routinely produced this way. Clear aligners are a particularly good example of the efficiency gains: traditional production requires printing a physical model of the patient’s teeth, then vacuum-forming plastic over that model. Direct 3D printing of the aligner skips both steps, saving time and material cost.
As printer prices have dropped, more orthodontic and dental offices have brought production in-house. A clinic with its own printer can design and fabricate an aligner or crown on-site rather than sending the job to an outside lab and waiting days for delivery. This compresses turnaround from days to hours for some restorations.
Bioprinting Living Tissue
The most ambitious frontier of medical 3D printing involves depositing living cells, layer by layer, to build functional tissue. A world-first clinical trial is currently underway at Concord Repatriation General Hospital in Sydney, where a handheld bioprinting device called LIGÅ is being used to treat patients with skin wounds, including burns. The device prints a cell-laden “ink” made from the patient’s own cells directly onto the wound, where it promotes skin regeneration.
The developers envision extending the technology to muscle, cartilage, and cornea repair. Full organ printing remains far off, but the ability to bioprint skin for burn patients and cartilage patches for joint injuries is moving from laboratory proof-of-concept into real clinical testing.
3D-Printed Medications
In 2015, the FDA approved the first 3D-printed drug: Spritam, a medication for epilepsy. The printing process creates an extremely porous tablet that disintegrates with a single sip of water, which is a significant advantage for patients who have difficulty swallowing pills, including many people with seizure disorders. It’s available in four dosage strengths (250, 500, 750, and 1,000 mg), and the precision of the printing process ensures consistent dosing across that range.
The broader promise of 3D-printed pharmaceuticals is personalized dosing. Rather than manufacturing millions of identical tablets, a pharmacy could theoretically print a pill with the exact dose a specific patient needs, combining multiple medications into a single tablet or adjusting release rates. That capability is still largely experimental, but Spritam demonstrated that the manufacturing and regulatory pathway is viable.
How These Devices Are Regulated
3D-printed medical devices go through the same FDA regulatory process as conventionally manufactured ones. A titanium skull plate printed at a hospital, for example, is classified as a Class II device and requires a formal submission to the FDA before it can be used, just as it would if it came from a traditional manufacturer. Simpler items like anatomical models or daily-activity assist devices fall under Class I, which has a lighter regulatory burden.
When hospitals print devices on-site (called point-of-care manufacturing), they take on the responsibilities of a manufacturer. That includes validating the entire production system before use, maintaining traceability for every printed device in case of a material recall, documenting the history of each device, and running a post-market surveillance program. Any post-processing steps, like polishing or sterilizing a printed implant, must be separately validated. The regulatory framework is designed to ensure that the speed and flexibility of 3D printing don’t come at the expense of patient safety.